Lean and obese Zucker rats exhibit different patterns of p70S6 kinase regulation In the tibialis anterior muscle In response TO high-force muscle contraction

Muscle and Nerve

Volumn 39, Issue 4, 2009, Pages 503-511

  Katta, Anjaiah ^a,b   Karkala, Sunil K ^a,b   Wu, Miaozong ^b   Meduru, Sarath ^b   Desai, Devashish H ^a   Rice, Kevin M ^a,b   Blough, Eric R ^a,b  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MARSHALL UNIVERSITY   (United States)

Author keywords

Insulin resistance; MTOR.; Obese Zucker rat; P70S6k; Skeletal muscle

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; S6 KINASE; SERINE; THREONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; ECCENTRIC MUSCLE CONTRACTION; ENZYME ACTIVATION; ENZYME REGULATION; EXERCISE; LEAN BODY WEIGHT; MALE; MUSCLE CONTRACTION; MUSCLE FORCE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TIBIALIS ANTERIOR MUSCLE;

ANIMALS; BODY WEIGHT; ELECTRIC STIMULATION; INSULIN; INSULIN RESISTANCE; MALE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; OBESITY; ORGAN SIZE; PHOSPHORYLATION; PHYSICAL EXERTION; RATS; RATS, ZUCKER; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SCIATIC NERVE; SIGNAL TRANSDUCTION;

EID: 65649154065     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21255     Document Type: Article

References (57)

1. Baar K, Esser K, Phosphorylation of p70 (S6k) correlates with increased skelet al. muscle mass following resistance exercise. Am J Physiol 1999; 76:C120-127. (Pubitemid 29063574)
2. Bassel-Duby R, Olson EN, Signaling pathways in skelet al. muscle remodeling. Annu Rev Biochem 2006; 75: 19-37. (Pubitemid 44118024)
3. Berthiaume N, Mika AK, Zinker BA. Development of insulin resistance and endothelin-1 levels in the Zucker fatty rat. Metabolism 2003; 52: 845-849. (Pubitemid 36949546)
4. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, et al. Akt/mTOR pathway is a crucial regulator of skelet al. muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 2001; 3: 1014-1019. (Pubitemid 34428747)
5. Brozinick JT Jr, Etgen GJ Jr, Yaspelkis BB III, Rang HY, Ivy JL. Effects of exercise training on muscle GLUT-4 protein content and translocation in obese Zucker rats. Am J Physiol 1993; 265: E419-427. (Pubitemid 23103936)
6. Bruce CR, Kriketos AD, Cooney GJ, HawleyJA. Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with Type 2 diabetes. Diabetologia 2004; 47: 23-30. (Pubitemid 38141936)
7. Cauza E, Hanusch-Enserer U, Strasser B, Ludvik B, Metz- Schimmerl S, Pacini G, et al. The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes rnellitus. Arch Phys Med Rehabil 2005; 86: 1527-1533. (Pubitemid 41115812)
8. Christ CY, Hunt D, Hancock J, Garcia-Macedo R, Mandarino LJ, Ivy JL. Exercise training improves muscle insulin resistance but not insulin receptor signaling in obese Zucker rats. J Appl Physiol 2002; 492: 736-744. (Pubitemid 34671044)
9. Coutant A, Rescan C, Gilot D. Loyer P, Guguen-Guillouzo C, Baffet G. PISK-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival. Hepatology 2002: 36: 1079-1088. (Pubitemid 35253423)
10. Crettaz M, Prentki M, Zaninetti D, Jeanrenaud B. Insulin resistance in soleus muscle from obese Zucker rats. Involvement of several defective sites. Biochem J 1980: 186: 525-534. (Pubitemid 10095959)
11. Diamond J. The double puzzle of diabetes. Nature 2003; 423: 599-602. (Pubitemid 36713209)
12. Dufner A, Thomas G. Ribosomal S6 kinase signaling and the control of translation. Exp Cell Res 1999; 253: 100-109.
13. Farrell PA, Fedele MJ, Hernandez J, Fluckey JD, Miller JL III, Lang CH. et al. Hypertrophy of skelet al. muscle in diabetic rats in response to chronic resistance exercise. J Appl Physiol 1999; 87: 1075-1082. (Pubitemid 29436986)
14. Fluckey JD, Pohnert SC, Boyd SG, Cortright RN, Trappe TA, Dohm GL. Insulin stimulation of muscle protein synthesis in obese Zucker rats is not via a rapamycin-sensitive pathway. Am J Physiol Endocrinol Metab 2000; 279: E182-187.
15. Geiger PC, Wright DC, Han DH, Holloszy JO. Activation of p38 MAP kinase enhances sensitivity of muscle glucose transport to insulin. Am J Physiol Endocrinol Metab 2005; 288: E782-788. (Pubitemid 40397215)
16. Gingras AC, Raught B, Sonenberg N. Regulation of translation Initiation by FRAP/mTOR. Genes Dev 2001; 115: 807-826. (Pubitemid 32295062)
17. Gosmanov AR, Umpierrez GE, Karabell AH, Cuervo R, Thomason DB. Impaired expression and insulin-stimulated phosphorylation of Akt-2 in muscle of obese patients with atypical diabetes. Am J Physiol Endocrinol Metab 2004; 287: E8-15. (Pubitemid 38856276)
18. Han XX, Chabowski A, Tandon NN, Calles-Escandon J, Glatz JF, Luiken JJ, et al. Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese Zucker rat muscle. Am J Physiol Endocrinol Metab 2007: 293: E566-575. (Pubitemid 47205101)
19. Hei YJ, Chen X, Pelech SL, Diamond J, McNeill JH. Skelet al. muscle mitogen-activated protein kinases and ribosomal S6 kinases. Suppression in chronic diabetic rats and reversal by vanadium. Diabetes 1995; 44: 1147-1155.
20. Holten MK, Zacho M, Caster M, Juel C, Wojtaszewski JF, Dela F. Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skelet al. muscle in patients with type 2 diabetes. Diabetes 2004; 53: 294-305.
21. Hornberger TA, Chu WK, Mak YW, HsiungJW, Huang SA, Chien S. The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skelet al. muscle. Proc Natl Acad Sci USA 2006; 103: 4741-4746.
22. Ionescu E, Sauter JF, Jeanrenaud B. Abnormal oral glucose tolerance in genetically obese (fa/fa) rats. Am J Physiol 1985; 248: E500-506. (Pubitemid 15018366)
23. Jefferies HB, Fumagalli S, Dennis PB, Reinhard C, Pearson RB, Thomas G. Rapamvcin suppresses 5'TOP mRNA translation through inhibition of P70s6k. EMBO J 1997; 16: 3693-3704. (Pubitemid 27250062)
24. Juel C, Holten MK, Dela F. Effects of strength training on muscle lactate release and MCT1 and MCT4 content in healthy and type 2 diabetic humans. J Physiol 2004; 556: 297-304. (Pubitemid 38515184)
25. Kim YB, Peroni OD, Franke TF, Kahn BB. Divergent regulation of Akt1 and Akt2 isoforms in insulin target tissues of obese Zucker rats. Diabetes 2000: 49: 847-856.
26. Kimball SR, Horetsky RL, Jefferson LS. Signal transduction pathways involved in the regulation of protein synthesis by insulin in L6 myoblasts. Am J Physiol 1998; 274: C221-228. (Pubitemid 28099362)
27. Laurent GJ, Millward DJ. Protein turnover during skelet al. muscle hypertrophy. Fed Proc 1980; 39: 42-47. (Pubitemid 10146115)
28. Lee CH, Inoki K, Guan KL. mTOR pathway as a target in tissue hypertrophy. Annu Rev Pharmacol Toxicol 2007; 47: 443-467. (Pubitemid 46272135)
29. Markuns JF, Napoli R, Hirshman MF, Davalli AM, Cheatham B, Goodyear LJ. Effects of streptozocin-induced diabetes and islet cell transplantation on insulin signaling in rat skelet al. muscle. Endocrinology 1999; 140: 106-111. (Pubitemid 29011147)
30. Martineau LC, Gardiner PF. Insight into skelet al. muscle mechanotransduction: MAPK activation is quantitatively related to tension. J Appl Physiol 2001; 91: 693-702.
31. Melian E, Gonzalez B, Ajo R, Gonzalez N, Sanchez Franco F, Tissue-specific response of IGF-I mRNA expression to obesityassociated GH decline in the male Zucker fatty rat. J Endocrinol 1999; 160: 49-56. (Pubitemid 29044567)
32. Mourani PM, Garl PJ, Wenzlau JM, Carpenter TC, Stenmark KR, Weiser-Evans MC. Unique, highly proliferative growth phenotype expressed by embryonic and neointimal smooth muscle cells is driven by constitutive Akt, mTOR, and p70S6K signaling and is actively repressed by P'l'EN. Circulation 2004; 109: 1299-1306.
33. Mylabathula DB, Rice KM, Wang Z, Uddemarri S, Kinnard RS, Blough ER. Age-associated changes in MAPK activation in fast- and slow-twitch skelet al. muscle of the F344/NNiaHSD X Brown Norway/BiNia rat model. Exp Gerontol 2006: 41: 205-214. (Pubitemid 43165693)
34. Nader GA, Esser KA, Intracellular signaling specificity in skelet al. muscle in response to different modes of exercise. J Appl Physiol 2001: 90: 1936-1942. (Pubitemid 32336480)
35. Oku A, Nawano M, Ueta K, Fujita T, Umebayashi I, Arakawa K, et al. Inhibitory effect of hyperglycemia on insulin-induced Akt/protein kinase B activation in skelet al. muscle. Am J Physiol Endocrinol Metab 2001; 280: E816-824. (Pubitemid 32466850)
36. Parkington JD, Siebert AP, LeBrasseur NK, Fielding RA. Differential activation of mTOR signaling by contractile activity in skelet al. muscle. Am J Physiol Regul Integr Comp Physiol 2003: 285: R1086-1090. (Pubitemid 36457395)
37. Parkington JD, LeBrasseur NK, Siebert AP, Fielding RA. Contraction-mediated mTOR, p70S6k, and ERK1/2 phosphorylation in aged skelet al. muscle. J Appl Physiol 2004; 97: 243-248.
38. Pearson RB, Thomas G. Regulation of p70s6k/p85s6k and its role in the cell cycle. Progr Cell Cycle Res 1995; 1: 21-32.
39. Peterson JM, Bryner RW, Alway SE. Satellite cell proliferation is reduced in muscles of obese Zucker rats but restored with loading. Am J Physiol Cell Physiol 2008; 295: C521-528. (Pubitemid 352755783)
40. Pullen N, Thomas G. The modular phosphorylation and activation of p70s6k. FEES Lett 1997: 410: 78-82. (Pubitemid 27283388)
41. Reynolds TH, Bodlne SC, Lawrence JC Jr. Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skelet al. muscle load. J Biol Cbem 2002; 277: 17657-17662. (Pubitemid 34106633)
42. Sakamoto K, Hirshman MF, Aschenbach WG, Goodyear LJ. Contraction regulation of Akt in rat skelet al. muscle. J Biol Chem 2002; 277: 11910-11917.
43. Scott PH, Lawrence JC Jr. Attenuation of mammalian target of rapamycin activity by increased cAMP in 3T3-L1 adipocytes. J Biol Chem 1998; 273: 34496-34501. (Pubitemid 29008930)
44. Sekulic A, Hudson CC, Homme JL, Yin P, Otterness DM, Karnitz LM, et al. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res 2000; 60: 3504-3513. (Pubitemid 30482170)
45. Shah OJ, Kimball SR, Jefferson LS. Glucocorticoids abate p70 (S6k) and eIF4E function in L6 skelet al. myoblasts. Am J Physiol Endocrinol Metab 2000; 279: E74-82. (Pubitemid 30609947)
46. 2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2. Biochem J 1998: 336: 241-246. (Pubitemid 28532583)
47. Somwar R, Perreault M. Kapur S, Taha C, Sweeney G, Ramlal T, et al. Activation of p38 mitogen-activated protein kinase alpha and beta by insulin and contraction in rat skelet al. muscle: potential role in the stimulation of glucose transport. Diabetes 2000; 49: 1794-1800.
48. Stickland NC, Batt RA, Crook AR, Sutton CM. Inability of muscles in the obese mouse (ob/ob) to respond to changes in body weight and activity. J Anat 1994; 184: 527-533. (Pubitemid 24186475)
49. Tokmakidis SP, Zois CE, Volaklis KA, Kotsa K, Touvra AM. The effects of a combined strength and aerobic exercise program on glucose control and insulin action in women with type 2 diabetes. Eur J Appl Physiol 2004; 92: 437-442. (Pubitemid 39248356)
50. Treadway JL, James DE, Burcel E, Ruderman NB. Effect of exercise on insulin receptor binding and kinase activity in skelet al. muscle. Am J Physiol 1989; 256: E138-144. (Pubitemid 19052113)
51. Turinsky J, Damrau-Abney A. Akt kinases and 2-deoxyglucose uptake in rat skelet al. muscles in vivo: study with insulin and exercise. Am j Physiol 1999; 276: R277-282. (Pubitemid 29061718)
52. Vanhaesebroeck B, Alessi DR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 2000; 346: 561-576. (Pubitemid 30171014)
53. Venojarvi M, Puhke R, Hamalainen H, Marniemi J, Rastas M, Rusko IT, et al. Role of skelet al. muscle-fibre type in regulation of glucose metabolism in middle-aged subjects with impaired glucose tolerance during a long-term exercise and dietary intervention. Diabetes Obes Metab 2005; 7: 745-754. (Pubitemid 41601080)
54. Wretman C, Lionikas A, Widegren U, Lannergren J, Westerblad H, Henriksson J. Effects of concentric and eccentric contractions on phosphoiylation of MAPK (erk1/2) and MAPK (p38) in isolated rat skelet al. muscle. J Physiol 2001; 535: 155-164. (Pubitemid 32782733)
55. Wu X, Reiter CE, Antonetti DA, Kimball SR, Jefferson LS, Gardner TW. Insulin promotes rat retinal neuronal cell survival in a p70S6K-dependent manner. J Biol Chem 2004; 279: 9167-9175. (Pubitemid 38295980)
56. Yarnada KM, Araki M. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J Cell Sci 2001; 114: 2375-2382.
57. Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, Bajraszewski N, et al. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 2003; 112: 1223-1233. (Pubitemid 38056299)